Curebase Selected Among Y Combinator’s Top Private Companies of 2023

DCT platform company places in top 6% of private companies; recognized for end-to-end clinical trial execution built on cutting-edge software SAN FRANCISCO, March 7, 2023 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, announced today that it has...

Click to view original post